Pathophysiology of Colon Flashcards
Colon anatomy
5’
tubular structure with all 5 layres
- inner circular, outer longitudinal smooth muscle layers
- ileocecal valve, internal and external anal sphincters
- NO villi
Multiple colonic functions
- water/ion absorption (ascending)
- bacterial fermentation of nonabsorbed nutrients (splenic flexure)
- storage of waste/indigestible materials (descending)
- elimination of waste/indigestible materials (rectum)
IBD pathophys
genetic susceptibility, immune dysregulation, environmental triggers
Diagnosis of IBD
When:
- suggestive symptoms > 2 weeks
- negative work-up for other causes of colitis (infection, ischemia, meds)
- extra-intestinal sxs
type of IBD
Ulcerative colitis, Crohn’s dz (10-20% have features of both)
signs/sxs of Ulcerative colitis
diarrhea, weight loss, fatigue, LOWER ad pain, Hematochezia, mcuus in stool, tenesmus (needing to defecate)
Crohn’s sxs
diarrhea, weight loss, fatigue, mid or lower abd pain, nausea/vomiting, fistula sxs
Crohns vs UC region affected
C: Entire GI tract
UC: Colon,
C vs UC: Obstruction
C: yes
UC: no
C vs UC: malabsorption?
C: Yes
UC: no
C vs UC: Malignant potential
C: with colonic involvement
UC: yes
C vs UC: recurrence after colectomy
C: common since can be affecting whole GI
UC: no
C vs UC: Toxic megacolon?
C: no
UC: yes
C vs UC: Inflammation- area affected
C: transmural
UC: mucosa and/or submucosa
C vs UC: Ulcers?
C: deep, linear
UC: superficial, confluent
C vs UC: Fibrosis?
C: Marked
UC: mild to none
C vs UC: Granulomas?
C: Yes- 20%
UC: No
Crohn’s fistula types
- entero-cutaneous
- entero-enteral,
- enterogastric,
- entero-vesical,
- entero-vaginal
Treatment of fistulas
usually requires biologic therapy or surgery
Extraintestinal manifestations
- mostly UC
- Eye– scleritis, episcleritis
- Skin – pyoderma gangenosum, erythema nodosum
Extraintestinal liver manifestations
Primary sclerosing cholangitis (PSC)
Joint involvement of IBD
sacroiliitis, ankylosing spondylitis
IBD management
Start with medical treatment - corticosteroids - 5-aminosalicylates Immunomodulators TNF-alpha antagonists
Surgery–colectomy, partial SB resection or stricturoplasty
(refractory dz, obstruction, fistula, HG dysplasia, or cancer)
Colon cancer surveillance
- risk increases with IBD duration
- yearly colonoscopy after 7-8 years
- biopsies from every segment
- LowGrade dysplasia common in IBD
- HighGrade dysplasia or cancer –> colectomy
Microscopic colitis prevalence
usually 50 -80, female: male 15:1
Microscopic colitis
autoimmune, trigger unknown
- salt and water loss in colon
Microscopic colitis presentation
chronic secretory diarrhea
- watery, non-bloody
- 4-10 stools per day
- minimal nocturnal or fasting sxs
Subtypes of microscopic colitis
Lymphocytic, collagenous
microscopic colitis association
mild association with celiac dz
Prognosis of microscopic colitis
good prognosis
- no bleeding, dehydration, or other complications
- no increase in cancer risk/mortility
Diagnosis of microscopic colitis
- colonoscopy usually normal
- Biopsy = definitive
lymphocytic infilatration ofmucosa and SM (LC); thickened collagenous band (CC
Histology
?